Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 3/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19940160 | 0.81 | ALDH1A1 (0.37) | CNR2CNR1ALDH1A1KDM4EHTT | |
| SCHEMBL12515246 | 0.77 | ALDH1A1 (0.51) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL19445684 | 0.77 | HTT (0.46) | CNR2CNR1ALDH1A1POLBIDH1 | |
| SCHEMBL12514989 | 0.76 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL10268065 | 0.75 | MAPK14 (0.41) | CNR2ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL12515253 | 0.75 | HTR4 (0.57) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL12515350 | 0.75 | MAPK14 (0.41) | CNR2ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL12514986 | 0.74 | ALDH1A1 (0.48) | ALDH1A1POLBKDM4EMEN1MAPT | |
| SCHEMBL12518639 | 0.74 | ALDH1A1 (0.48) | ALDH1A1POLBKDM4EMEN1MAPT | |
| SCHEMBL19445831 | 0.72 | ALDH1A1 (0.42) | ALDH1A1KDM4EMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | POLYMEDIX, INC. | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | MUC1, FUT6, SI | CNR2 3195/4885CNR1 3769/4885ALDH1A1 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.